Navigation Links
Also in the June 24 JNCI
Date:6/24/2008

Identification of a Tumor Suppressor Gene Associated with Patient Outcome in Neuroblastoma

Expression of the CHD5 gene is frequently down-regulated in neuroblastomas, and patients whose tumors lacked CHD5 expression were more likely to have shorter event-free and overall survival compared with patients whose tumors expressed CHD5.

Neuroblastoma tumors often lack one copy of a region on the short arm of chromosome 1, called 1p36.31. Garrett Brodeur, M.D., of the Children's Hospital of Philadelphia and colleagues previously identified the smallest region spanned by the deletion in more than 1,200 patient tumors and found that 23 genes were located within the region.

In the current study, Brodeur and colleagues examined the expression pattern of CHD5 in neuroblastoma cell lines and the impact of replacing the missing copy of this gene in animal models. They also looked at the association between expression of each of the 23 genes from the region and clinical outcome in 99 patients.

Although the remaining copy of the CHD5 gene is rarely mutated in neuroblastomas, the authors found that the gene is epigenetically silenced in neuroblastoma cell lines with 1p deletion. Patients whose tumors showed high expression of CHD5 protein had approximately 7-fold longer event-free and overall survival than those patients whose tumor showed low CHD5 expression. Other genes in the region did not show a consistent association with neuroblastoma prognostic features and patient outcomes.

"These results demonstrate that CHD5 expression is strongly associated with outcome in neuroblastomas, CHD5 is the likely target of 1p deletions in these tumors, and it may have a direct role in the biology and behavior of neuroblastomas," the authors write.

Contact: Ashley Moore, moorea1@chop.edu, (267) 426-6071


Intestinal Proteins May Be Effective Anti-Tumor Antigens


'/>"/>
Contact: Liz Savage
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
Source:Eurekalert

Page: 1 2 3 4 5

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2015 ANT Wireless, proven innovator in ... of two new products implementing the ANT+ Fitness Equipment ... wireless interoperability in their bike trainer products, built to ... has implemented the FE-C device profile in its Vortex ... its new indoor training software, while Kinomap has added ...
(Date:6/2/2015)... BRANFORD, CT (PRWEB) June 02, 2015 Acara ... launching websites that are responsive to mobile devices, as is ... “Many of our current clients, as well as several new ... to develop a responsive website for them to meet Google’s ... is also the case with our clients in education, non-profits, ...
(Date:6/2/2015)... June 02, 2015 Though almost the entire ... to let the disease rule their lives. Organizing and hosting ... dedication to living life to the fullest and spreading awareness ... about it, but I won't live my life in a ... last thing you'd want is to look back on your ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Vancouver, ... by iData Research ( http://www.idataresearch.com ), the bone ... demineralized bone matrices (DBM) over traditional allograft materials. ... incisions and thus an increase in operation time, ... strong market growth in these synthetic materials is ...
(Date:6/2/2015)... June 02, 2015 Recent findings from ... that while there has been a reduction in conventional ... and waterpipe vapor (hookah) usage has doubled among today’s ... Dr. Russell Gombosi believes the national trend is consistent ... take 15 to 20 years to fully determine the ...
Breaking Medicine News(10 mins):Health News:First ANT FE-C Enabled Fitness Products Enter Market 2Health News:First ANT FE-C Enabled Fitness Products Enter Market 3Health News:Acara Partners Expands Website and Digital Offerings 2Health News:Family brings awareness to genetic disease at first Memphis walk 2Health News:Medtronic, DePuy Synthes Shift U.S. Bone Graft Substitute Market Towards Synthetic Demineralized Bone Matrices 2Health News:Medtronic, DePuy Synthes Shift U.S. Bone Graft Substitute Market Towards Synthetic Demineralized Bone Matrices 3Health News:Susquehanna Health Pediatrician Warns of Adverse Effects of Teen E-Cigarette Usage 2Health News:Susquehanna Health Pediatrician Warns of Adverse Effects of Teen E-Cigarette Usage 3
... News) -- Practice is an essential part of gaining excellence ... qualities must come into play, such as IQ or working ... success of chess players. For the study, published ... Science , the researchers also considered earlier research and noted ...
... , FRIDAY, Oct. 28 (HealthDay News) -- ... their brain disease also take drugs that counter the ... Clinical trials have shown that cholinesterase inhibitors such ... functional and cognitive decline caused by Alzheimer,s disease, noted ...
... received a five-year, $7.56 million grant from the National Institute ... (NIH) to evaluate the efficacy and cost-effectiveness of a peer-driven ... in their communities, test them for HIV, and link them ... to be HIV infected. An estimated 25% of individuals ...
... 2008, as part of a larger initiative aimed at reducing ... the treatment of injuries related to in-hospital falls. , Geriatricians ... an unintended negative consequence. In trying to keep elderly ... might discourage patients from moving about at all. And ...
... , FRIDAY, Oct. 28 (HealthDay News) -- Preschool ... if they,re placed in a classroom with higher-achieving children, ... researchers say. The findings are important because many ... poor children, whose development of language skills may be ...
... studied in non-human primates by researchers at Wake Forest ... a potential tool for combating cardiovascular disease by increasing ... Supported by the National Institutes of Health and the ... in this week,s issue of the journal Nature ...
Cached Medicine News:Health News:Practice Doesn't Always Make Perfect, Study Suggests 2Health News:Some People With Alzheimer's Take Conflicting Drugs 2Health News:NYUCN receives $7.56 million NIH grant to research heterosexuals at high risk of HIV infection 2Health News:NYUCN receives $7.56 million NIH grant to research heterosexuals at high risk of HIV infection 3Health News:NYUCN receives $7.56 million NIH grant to research heterosexuals at high risk of HIV infection 4Health News:Study finds no link between elderly patient activity and hospital falls 2Health News:Preschool Peers May Boost Language Skills in Kids 2Health News:New therapy shows promise for treating cardiovascular disease 2
(Date:6/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/ctd7zx/europe ) has announced the addition of ... (2014 - 2019)" report to their offering. ... Germany . This is followed by UK and ... Poland are the fastest growing segments. ... the basis of Product (Film Screen, Digital, 3D, Analog Systems, ...
(Date:6/2/2015)... Texas , June 2, 2015 ... report defines and segments the concerned market with ... valued at $261.8 million in 2014, and is ... a CAGR of 19.3% from 2014 to 2019. ... America Mannequin-Based Simulation Market for an analysis of ...
(Date:6/2/2015)... 2015 Intarcia Therapeutics, Inc. today ... its recently announced synthetic royalty / equity convert financing, ... have purchased Convertible Limited Recourse Notes from Intarcia and ... of any future global net sales of ITCA 650 ... also have the option, commencing upon U.S. regulatory approval ...
Breaking Medicine Technology:Europe Mammography Market Report 2014-2019 - Growth, Trends And Forecasts 2North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 2North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 3Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 2Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 3
... , DETROIT, Dec. 30 For the twelfth consecutive ... of Christ, is campaigning to save lives during New Year,s ... the New Millennium, Health Alliance Plan (HAP) and the Wayne ... to celebrate the New Year without gunfire. The hope ...
... Conn., Dec. 30 VION PHARMACEUTICALS, INC. (OTC ... Food and Drug Administration ("FDA") had responded to its Special ... trial HOVON AML 92 sponsored by the Dutch-Belgian Cooperative Group ... FDA raised concerns with the HOVON trial design as submitted ...
Cached Medicine Technology:Rev. Nick Hood, III Asks Southeast Michiganders Not to Use Guns During New Year's Eve Celebrations 2Vion Pharmaceuticals Announces FDA Conclusion 2Vion Pharmaceuticals Announces FDA Conclusion 3
... Vessel Dissector has application for use in ... the extraperitoneal spaces such as the retroperitoneal, ... be used in surgical procedures requiring dissection ... harvesting of a quality conduit through a ...
... The Thoratec VAD System includes three ... Drive Console or TLC-II Portable Driver. This ... when the natural heart, with conventional therapy, ... perfuse vital organs. To accomplish support, blood ...
... two distinct polyethylene glycol polymers that combine to ... to chemically bond to each other, as well ... material forms a flexible, watertight seal that remains ... withstand arterial pressure. It is completely resorbed by ...
The Icy catheter is inserted into the femoral vein and resides in the inferior vena cava. Saline flow within the balloons creates a proprietary vortex flow pattern which maximizes heat exchange with...
Medicine Products: